<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
      <PMID Version="1">34751445</PMID>
      <DateCompleted>
        <Year>2022</Year>
        <Month>03</Month>
        <Day>14</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>03</Month>
        <Day>14</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1440-0960</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>63</Volume>
            <Issue>1</Issue>
            <PubDate>
              <Year>2022</Year>
              <Month>Feb</Month>
            </PubDate>
          </JournalIssue>
          <Title>The Australasian journal of dermatology</Title>
          <ISOAbbreviation>Australas J Dermatol</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Hypopigmented lesions in pityriasis lichenoides chronica patients: Are they only post-inflammatory hypopigmentation?</ArticleTitle>
        <Pagination>
          <StartPage>68</StartPage>
          <EndPage>73</EndPage>
          <MedlinePgn>68-73</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1111/ajd.13746</ELocationID>
        <Abstract>
          <AbstractText Label="BACKGROUND/OBJECTIVES" NlmCategory="OBJECTIVE">Pityriasis lichenoides chronica (PLC) lesions are reported to subside with post-inflammatory hypopigmentation (PIH); hence, the most widely perceived nature of hypopigmented macules in PLC is PIH. However, to the best of our knowledge, no studies describing histopathological findings in these lesions are reported in literature. The aim of this study is to evaluate the hypopigmented lesions encountered in PLC patients and to shed light on their histopathological features.</AbstractText>
          <AbstractText Label="METHODS" NlmCategory="METHODS">A cross-sectional observational study included twenty-one patients with PLC recruited in a period of twelve months. Clinical characteristics of each patient were collected. A skin biopsy from hypopigmented lesions whenever present was taken and assessed with routine haematoxylin and eosin stain.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">Seventeen patients (81%) were less than 13 years old. Most patients (85.7%) demonstrated diffuse distribution of lesions. Hypopigmented lesions were present on the face in 12 (57.14%) patients. Histopathologically, hypopigmented lesions showed features of post-inflammatory hypopigmentation in 19% of patients, residual PLC in 52.4% and active PLC 28.6% of patients.</AbstractText>
          <AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Hypopigmented lesions in PLC were noted mainly in younger ages, histopathologically they may show features of active or residual disease, beyond post-inflammatory hypopigmentation. Consequently active treatment for patients presenting predominantly with hypopigmented lesions could be required to control the disease.</AbstractText>
          <CopyrightInformation>© 2021 Australasian College of Dermatologists.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Elbendary</LastName>
            <ForeName>Amira</ForeName>
            <Initials>A</Initials>
            <Identifier Source="ORCID">0000-0001-5003-0994</Identifier>
            <AffiliationInfo>
              <Affiliation>Dermatology Department, Kasr Alainy Faculty of Medicine, Cairo University, Cairo, Egypt.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Abdel-Halim</LastName>
            <ForeName>Mona R E</ForeName>
            <Initials>MRE</Initials>
            <AffiliationInfo>
              <Affiliation>Dermatology Department, Kasr Alainy Faculty of Medicine, Cairo University, Cairo, Egypt.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Youssef</LastName>
            <ForeName>Randa</ForeName>
            <Initials>R</Initials>
            <AffiliationInfo>
              <Affiliation>Dermatology Department, Kasr Alainy Faculty of Medicine, Cairo University, Cairo, Egypt.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Abdel Halim</LastName>
            <ForeName>Dalia</ForeName>
            <Initials>D</Initials>
            <AffiliationInfo>
              <Affiliation>Dermatology Department, Kasr Alainy Faculty of Medicine, Cairo University, Cairo, Egypt.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Elmasry</LastName>
            <ForeName>Maha Fathy</ForeName>
            <Initials>MF</Initials>
            <Identifier Source="ORCID">0000-0002-3873-3897</Identifier>
            <AffiliationInfo>
              <Affiliation>Dermatology Department, Kasr Alainy Faculty of Medicine, Cairo University, Cairo, Egypt.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Gad</LastName>
            <ForeName>Abdallah</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Lowell General Hospital, Lowell, MA, USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Biostatistics and Cancer Epidemiology Department, National Cancer Institute, Cairo University, Cairo, Egypt.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>El Sharkawy</LastName>
            <ForeName>Dina Ahmed</ForeName>
            <Initials>DA</Initials>
            <AffiliationInfo>
              <Affiliation>Dermatology Department, Kasr Alainy Faculty of Medicine, Cairo University, Cairo, Egypt.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D064888">Observational Study</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2021</Year>
          <Month>11</Month>
          <Day>09</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>Australia</Country>
        <MedlineTA>Australas J Dermatol</MedlineTA>
        <NlmUniqueID>0135232</NlmUniqueID>
        <ISSNLinking>0004-8380</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D017496" MajorTopicYN="N">Hypopigmentation</DescriptorName>
          <QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D017514" MajorTopicYN="N">Pityriasis Lichenoides</DescriptorName>
          <QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">hypopigmented</Keyword>
        <Keyword MajorTopicYN="N">pityriasis lichenoides chronica</Keyword>
        <Keyword MajorTopicYN="N">post-inflammatory hypopigmentation</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="revised">
          <Year>2021</Year>
          <Month>10</Month>
          <Day>11</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="received">
          <Year>2021</Year>
          <Month>9</Month>
          <Day>7</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2021</Year>
          <Month>10</Month>
          <Day>18</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2021</Year>
          <Month>11</Month>
          <Day>10</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>3</Month>
          <Day>15</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2021</Year>
          <Month>11</Month>
          <Day>9</Day>
          <Hour>9</Hour>
          <Minute>23</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">34751445</ArticleId>
        <ArticleId IdType="doi">10.1111/ajd.13746</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Title>REFERENCES</Title>
        <Reference>
          <Citation>Gelmetti C, Rigoni C, Alessi E et al. Pityriasis lichenoides in children: a long-term follow-up of eighty-nine cases. J. Am. Acad. Dermatol. 1990; 23: 473-8.</Citation>
        </Reference>
        <Reference>
          <Citation>Markus JR, Carvalho VO, Lima MN et al. The relevance of recognizing clinical and morphologic features of pityriasis lichenoides: clinicopathological study of 29 cases. Dermatol. Pract. Concept. 2013; 3: 7-10.</Citation>
        </Reference>
        <Reference>
          <Citation>Joshi R. Stratum corneum findings as clues to histological diagnosis of pityriasis lichenoides chronica. Indian. J. Dermatol. Venereol. Leprol. 2008; 74: 156-7.</Citation>
        </Reference>
        <Reference>
          <Citation>Magro CM, Crowson AN, Morrison C et al. Pityriasis lichenoides chronica: stratification by molecular and phenotypic profile. Hum. Pathol. 2007; 38: 479-90.</Citation>
        </Reference>
        <Reference>
          <Citation>Clayton R, Warin A. Pityriasis lichenoides chronica presenting as hypopigmentation. Br. J. Dermatol. 1979; 100: 297-302.</Citation>
        </Reference>
        <Reference>
          <Citation>Lane TN, Parker SS. Pityriasis lichenoides chronica in black patients. Cutis 2010; 85: 125-9.</Citation>
        </Reference>
        <Reference>
          <Citation>Hapa A, Ersoy-Evans S, Karaduman A. Childhood pityriasis lichenoides and oral erythromycin. Pediatr. Dermatol. 2012; 29: 719-24.</Citation>
        </Reference>
        <Reference>
          <Citation>Pimpinelli N, Olsen EA, Santucci M et al. Defining early mycosis fungoides. J. Am. Acad. Dermatol. 2005; 53: 1053-63.</Citation>
        </Reference>
        <Reference>
          <Citation>Cerroni L. Mycosis Fungoides. In: Skin Lymphoma, the Illustrated Guide, 4th edn. Singapore City, Singapore: Wiley-Blackwell, 2014; 11-73.</Citation>
        </Reference>
        <Reference>
          <Citation>Abdel-Halim M, El-Nabarawy E, El Nemr R et al. Frequency of hypopigmented mycosis fungoides in Egyptian patients presenting with hypopigmented lesions of the trunk. Am. J. Dermatopathol. 2015; 37: 834-40.</Citation>
        </Reference>
        <Reference>
          <Citation>Chan YH. Biostatistics 103: qualitative data - tests of independence. Singapore. Med. J. 2003; 44: 498-503.</Citation>
        </Reference>
        <Reference>
          <Citation>Chan YH. Biostatistics 102: quantitative data-parametric &amp; non-parametric tests. Singapore. Med. J. 2003; 44: 391-6.</Citation>
        </Reference>
        <Reference>
          <Citation>Magro C, Crowson AN, Kovatich A et al. Pityriasis lichenoides: a clonal T-cell lymphoproliferative disorder. Hum. Pathol. 2002; 33: 788-95.</Citation>
        </Reference>
        <Reference>
          <Citation>Kempf W, Kazakov DV, Palmedo G et al. Pityriasis lichenoides et varioliformis acuta with numerous CD30(+) cells: a variant mimicking lymphomatoid papulosis and other cutaneous lymphomas. A clinicopathologic, immunohistochemical, and molecular biological study of 13 cases. Am. J. Surg. Pathol. 2012; 36: 1021-9.</Citation>
        </Reference>
        <Reference>
          <Citation>Magro CM, Crowson AN, Kovatich AJ et al. Drug-induced reversible lymphoid dyscrasia: a clonal lymphomatoid dermatitis of memory and activated T cells. Hum. Pathol. 2003; 34: 119-29.</Citation>
        </Reference>
        <Reference>
          <Citation>Shieh S, Mikkola DL, Wood GS. Differentiation and clonality of lesional lymphocytes in pityriasis lichenoides chronica. Arch. Dermatol. 2001; 137: 305-8.</Citation>
        </Reference>
        <Reference>
          <Citation>Weinberg JM, Kristal L, Chooback L et al. The clonal nature of pityriasis lichenoides. Arch. Dermatol. 2002; 138: 1063-7.</Citation>
        </Reference>
        <Reference>
          <Citation>Furlan FC, Sanches JA. Hypopigmented mycosis fungoides: a review of its clinical features and pathophysiology. An. Bras. Dermatol. 2013; 88: 954-60.</Citation>
        </Reference>
        <Reference>
          <Citation>Zaaroura H, Sahar D, Bick T et al. Relationship between pityriasis lichenoides and mycosis fungoides: a clinicopathological, immunohistochemical, and molecular study. Am. J. Dermatopathol. 2018; 40: 409-15.</Citation>
        </Reference>
        <Reference>
          <Citation>Ardigó M, Borroni G, Muscardin L et al. Hypopigmented mycosis fungoides in Caucasian patients: a clinicopathologic study of 7 cases. J. Am. Acad. Dermatol. 2003; 49: 264-70.</Citation>
        </Reference>
        <Reference>
          <Citation>Das JK, Gangopadhyay AK. Mycosis fungoides with unusual vitiligo-like presentation. Indian. J. Dermatol. Venereol. Leprol. 2004; 70: 304-6.</Citation>
        </Reference>
        <Reference>
          <Citation>Chuang GS, Wasserman DI, Byers HR et al. Hypopigmented T-cell dyscrasia evolving to hypopigmented mycosis fungoides during etanercept therapy. J. Am. Acad. Dermatol. 2008; 59(Suppl. 5): S121-2.</Citation>
        </Reference>
        <Reference>
          <Citation>Singh ZN, Tretiakova MS, Shea CR et al. Decreased CD117 expression in hypopigmented mycosis fungoides correlates with hypomelanosis: lessons learned from vitiligo. Mod. Pathol. 2006; 19: 1255-60.</Citation>
        </Reference>
        <Reference>
          <Citation>Moretti S, Spallanzani A, Amato L et al. New insights into the pathogenesis of vitiligo: imbalance of epidermal cytokines at sites of lesions. Pigment. Cell. Res. 2002; 15: 87-92.</Citation>
        </Reference>
        <Reference>
          <Citation>Seif El Nasr H, Shaker OG, Fawzi MM et al. Basic fibroblast growth factor and tumour necrosis factor alpha in vitiligo and other hypopigmented disorders: suggestive possible therapeutic targets. J. Eur. Acad. Dermatol. Venereol. 2013; 27: 103-8.</Citation>
        </Reference>
        <Reference>
          <Citation>Youssef R, Mahgoub D, Zeid OA et al. Hypopigmented interface T-cell dyscrasia and hypopigmented mycosis fungoides: a comparative study. Am. J. Dermatopathol. 2018; 40: 727-35.</Citation>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
